Medication included:
Enzalutamide (Xtandi®)
Program Period:
From 15th March 2019 until further notice
Applicants’ Criteria:
1. A Valid Hong Kong Identity Card (HKID) Holder
2. A Patient from Private Practice Urologists or Oncologists Registered in Hong Kong
3. Disease Status:
• Castration-Resistant Prostate Cancer
• Confirmed Metastases
4. Financial Status: Individual Annual Disposable Income less than HKD 1.5 million
5. Hold valid prescriptions and named receipts (original or certified true copy) or a purchase record booklet of Xtandi® verified by your private practice urologists and oncologists
6. Applicants should not apply and enroll into other capping and subsidy programs of Xtandi® if he is successfully enrolled into Xtandi® private capping program under SafeMed Dispensary of HKPCF
For program details, application method and the collection of free drugs of “Xtandi® (Enzalutamide) - Private Capping Program”, please kindly contact SafeMed Dispensary at 2979 0380.